BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2775246)

  • 1. Response of different mammary epithelial cell lines to a mammary derived growth inhibitor (MDGI).
    Lehmann W; Widmaier R; Langen P
    Biomed Biochim Acta; 1989; 48(1):143-51. PubMed ID: 2775246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local control of mammary gland differentiation: mammary-derived growth inhibitor and pleiotrophin.
    Kurtz A; Spitzer E; Zschiesche W; Wellstein A; Grosse R
    Biochem Soc Symp; 1998; 63():51-69. PubMed ID: 9513711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiprogestins inhibit growth and stimulate differentiation in the normal mammary gland.
    Li M; Spitzer E; Zschiesche W; Binas B; Parczyk K; Grosse R
    J Cell Physiol; 1995 Jul; 164(1):1-8. PubMed ID: 7790381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal calf serum and epidermal growth factor prevent the inhibitory action of a chalone-like growth inhibitor for Ehrlich ascites mammary carcinoma cells in vitro.
    Lehmann W; Graetz H; Widmayer R; Langen P
    Biomed Biochim Acta; 1984; 43(7):971-4. PubMed ID: 6240265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On a "chalone"-like factor for Ehrlich ascites mammary carcinoma.
    Lehmann W; Graetz H; Samtleben R; Schütt M; Langen P
    Acta Biol Med Ger; 1980; 39(1):93-105. PubMed ID: 6448529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer growth inhibition by delivery of the MDGI-derived peptide P108.
    Wang HL; Kurtz A
    Oncogene; 2000 May; 19(20):2455-60. PubMed ID: 10828888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polypeptide growth inhibitor isolated from lactating bovine mammary gland (MDGI) is a lipid-carrying protein.
    Böhmer FD; Mieth M; Reichmann G; Taube C; Grosse R; Hollenberg MD
    J Cell Biochem; 1988 Nov; 38(3):199-204. PubMed ID: 3230093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
    J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and function dependent localization of mammary derived growth inhibitor (MDGI) in mammary glands of bovine and mice.
    Vogel F; Breter H; Erdmann B; Müller T; Binas B; Grosse R
    Acta Histochem Suppl; 1990; 40():77-80. PubMed ID: 2091050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen.
    van der Burg B; Rutteman GR; Blankenstein MA; de Laat SW; van Zoelen EJ
    J Cell Physiol; 1988 Jan; 134(1):101-8. PubMed ID: 3275677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture.
    Imai Y; Leung CK; Friesen HG; Shiu RP
    Cancer Res; 1982 Nov; 42(11):4394-8. PubMed ID: 6290036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor.
    Huynh HT; Larsson C; Narod S; Pollak M
    Cancer Res; 1995 Jun; 55(11):2225-31. PubMed ID: 7757968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and continuous passage of COMMA-D mouse mammary epithelial cells in hormonally defined serum-free medium.
    Riss TL; Sirbasku DA
    Cancer Res; 1987 Jul; 47(14):3776-82. PubMed ID: 3297308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG; Hosick HL; Ethier SP
    J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of mammary-derived growth inhibitor messenger RNA by antiestrogens.
    Huynh H; Pollak M
    Clin Cancer Res; 1997 Nov; 3(11):2151-6. PubMed ID: 9815609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid modulation of epidermal growth factor-induced mouse mammary epithelial cell proliferation in vitro.
    Sylvester PW; Birkenfeld HP; Hosick HL; Briski KP
    Exp Cell Res; 1994 Sep; 214(1):145-53. PubMed ID: 8082717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of transforming growth factors in human breast cancer cells.
    Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
    Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of the mammary-derived growth inhibitor (MDGI) gene in breast neoplasms is associated with epigenetic changes.
    Huynh H; Alpert L; Pollak M
    Cancer Res; 1996 Nov; 56(21):4865-70. PubMed ID: 8895735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of thymidine uptake and cell proliferation in mouse embryo fibroblasts by conditioned medium from mammary cells in culture.
    Howard EF; Scott DF; Bennett CE
    Cancer Res; 1976 Dec; 36(12):4543-51. PubMed ID: 1000499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.